Fluent Financial, LLC Bristol Myers Squibb CO Transaction History

Fluent Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$61.91 - $67.42 $3.94 Million - $4.29 Million	-63,638 Closed	0 $0
Q4 2020 Jan 22, 2021	SELL	$57.74 - $65.43 $1.59 Million - $1.8 Million	-27,527 Reduced 30.19%	63,638 $3.95 Million
Q3 2020 Oct 16, 2020	SELL	$57.43 - $63.64 $24,809 - $27,492	-432 Reduced 0.47%	91,165 $5.5 Million
Q2 2020 Jul 15, 2020	BUY	$54.82 - $64.09 $346,791 - $405,433	6,326 Added 7.42%	91,597 $5.39 Million
Q1 2020 Apr 28, 2020	BUY	$46.4 - $67.43 $661,339 - $961,079	14,253 Added 20.07%	85,271 $4.75 Million

Q4 2019 Jan 17, 2020	BUY	$49.21 - $64.19 $3.49 Million - $4.56 Million	71,018 New	71,018 $4.56 Million

2,555

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fluent Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Fluent Financial, LLC with notifications on news.